Gestational birth age is strongly correlated with central macular thickness

Article

Prematurely born children have a thicker central macular than children born at term

A recent study featured in the British Journal of Ophthalmology has demonstrated that prematurely born children have a thicker central macular than children born at term.

Professor Gerd Holmström et al., Department of Ophthalmology, University Hospital, Sweden, studied 65 prematurely born children between the ages of 5–16 years and 55 children born at term with Stratus optical coherence tomography (OCT). The foveal minimum, total macular volume and retinal macular thickness in nine macular areas were evaluated.

There was no correlation between macular thickness and refraction or visual acuity. It was found that children with previous retinopathy of prematurity (ROP) had a thicker macular than those who didn't. Children born without ROP still had a thicker macular than the control group. The results revealed that prematurity highly influences central macular thickness and is the most significant risk factor for abnormal foeval development.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.